Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Radiotherapy as an Adjunct to Surgery for Pancreatic Cancer: Where Are We After More Than 30 Years of Research and Trials?

Ferrantella A, Dudeja V, Are C.

Ann Surg Oncol. 2019 Oct 11. doi: 10.1245/s10434-019-07787-w. [Epub ahead of print] No abstract available.

PMID:
31605341
2.

Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.

Giri B, Gupta VK, Yaffe B, Modi S, Roy P, Sethi V, Lavania SP, Vickers SM, Dudeja V, Banerjee S, Watts J, Saluja A.

J Transl Med. 2019 Sep 4;17(1):301. doi: 10.1186/s12967-019-2048-3.

3.

Unconventional T Cells in the Pancreatic Tumor Microenvironment: Thinking Outside the Box.

Banerjee S, Dudeja V, Saluja A.

Cancer Discov. 2019 Sep;9(9):1164-1166. doi: 10.1158/2159-8290.CD-19-0722.

PMID:
31481406
4.

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity.

Garrido G, Schrand B, Rabasa A, Levay A, D'Eramo F, Berezhnoy A, Modi S, Gefen T, Marijt K, Doorduijn E, Dudeja V, van Hall T, Gilboa E.

Nat Commun. 2019 Aug 21;10(1):3773. doi: 10.1038/s41467-019-11728-2.

5.

Extracellular release of ATP promotes systemic inflammation during acute pancreatitis.

Dixit A, Cheema H, George J, Iyer S, Dudeja V, Dawra R, Saluja AK.

Am J Physiol Gastrointest Liver Physiol. 2019 Oct 1;317(4):G463-G475. doi: 10.1152/ajpgi.00395.2018. Epub 2019 Aug 21.

PMID:
31433214
6.

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.

Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB.

Ann Surg. 2019 Sep;270(3):400-413. doi: 10.1097/SLA.0000000000003468.

PMID:
31283563
7.

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability.

Sharma NS, Gupta VK, Dauer P, Kesh K, Hadad R, Giri B, Chandra A, Dudeja V, Slawson C, Banerjee S, Vickers SM, Saluja A, Banerjee S.

Theranostics. 2019 May 24;9(12):3410-3424. doi: 10.7150/thno.32615. eCollection 2019.

8.

Correction: Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.

Banerjee S, Sangwan V, McGinn O, Chugh R, Dudeja V, Vickers SM, Saluja AK.

J Biol Chem. 2019 Jul 5;294(27):10739. doi: 10.1074/jbc.AAC119.009844. No abstract available.

9.

Does Neoadjuvant Chemotherapy Change the Role of Regional Lymphadenectomy in Pancreatic Cancer Survival?

Macedo FI, Picado O, Hosein PJ, Dudeja V, Franceschi D, Mesquita-Neto JW, Yakoub D, Merchant NB.

Pancreas. 2019 Jul;48(6):823-831. doi: 10.1097/MPA.0000000000001339.

PMID:
31210664
10.

Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.

Giri B, Gupta VK, Yaffe B, Modi S, Roy P, Sethi V, Lavania SP, Vickers SM, Dudeja V, Banerjee S, Watts J, Saluja A.

J Transl Med. 2019 May 20;17(1):163. doi: 10.1186/s12967-019-1901-8. Erratum in: J Transl Med. 2019 Sep 4;17(1):301.

11.

Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution.

Creasy JM, Goldman DA, Gonen M, Dudeja V, O'Reilly EM, Abou-Alfa GK, Cercek A, Harding JJ, Balachandran VP, Drebin JA, Allen PJ, Kingham TP, D'Angelica MI, Jarnagin WR.

HPB (Oxford). 2019 Apr 23. pii: S1365-182X(19)30496-4. doi: 10.1016/j.hpb.2019.03.370. [Epub ahead of print]

PMID:
31027875
12.

Early Intra-Acinar Events in Pathogenesis of Pancreatitis.

Saluja A, Dudeja V, Dawra R, Sah RP.

Gastroenterology. 2019 May;156(7):1979-1993. doi: 10.1053/j.gastro.2019.01.268. Epub 2019 Feb 15. Review.

PMID:
30776339
13.

The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy.

Sethi V, Vitiello GA, Saxena D, Miller G, Dudeja V.

Gastroenterology. 2019 May;156(7):2097-2115.e2. doi: 10.1053/j.gastro.2018.12.045. Epub 2019 Feb 12. Review.

PMID:
30768986
14.

ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining "stemness".

Dauer P, Sharma NS, Gupta VK, Durden B, Hadad R, Banerjee S, Dudeja V, Saluja A, Banerjee S.

Cell Death Dis. 2019 Feb 12;10(2):132. doi: 10.1038/s41419-019-1408-5.

15.

Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.

Moran A, Ramos LF, Picado O, Pendola F, Sleeman D, Dudeja V, Merchant N, Yakoub D.

J Surg Oncol. 2019 Mar;119(4):455-463. doi: 10.1002/jso.25338. Epub 2018 Dec 21.

PMID:
30575028
16.

Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.

Gupta VK, Sharma NS, Kesh K, Dauer P, Nomura A, Giri B, Dudeja V, Banerjee S, Bhattacharya S, Saluja A, Banerjee S.

Cancer Lett. 2018 Dec 28;439:101-112. doi: 10.1016/j.canlet.2018.09.028. Epub 2018 Oct 2.

PMID:
30290209
17.

Long-term Quality of Life and Gastrointestinal Functional Outcomes After Pancreaticoduodenectomy.

Allen CJ, Yakoub D, Macedo FI, Dosch AR, Brosch J, Dudeja V, Ayala R, Merchant NB.

Ann Surg. 2018 Oct;268(4):657-664. doi: 10.1097/SLA.0000000000002962.

PMID:
30199443
18.

NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.

Garg B, Giri B, Modi S, Sethi V, Castro I, Umland O, Ban Y, Lavania S, Dawra R, Banerjee S, Vickers S, Merchant NB, Chen SX, Gilboa E, Ramakrishnan S, Saluja A, Dudeja V.

Gastroenterology. 2018 Sep;155(3):880-891.e8. doi: 10.1053/j.gastro.2018.05.051. Epub 2018 Jul 29.

19.

GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells.

Dauer P, Sharma NS, Gupta VK, Nomura A, Dudeja V, Saluja A, Banerjee S.

Mol Oncol. 2018 Sep;12(9):1498-1512. doi: 10.1002/1878-0261.12322. Epub 2018 Aug 7.

20.

Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.

Sethi V, Kurtom S, Tarique M, Lavania S, Malchiodi Z, Hellmund L, Zhang L, Sharma U, Giri B, Garg B, Ferrantella A, Vickers SM, Banerjee S, Dawra R, Roy S, Ramakrishnan S, Saluja A, Dudeja V.

Gastroenterology. 2018 Jul;155(1):33-37.e6. doi: 10.1053/j.gastro.2018.04.001. Epub 2018 Apr 7.

21.

Pancreatitis: A Tale of Two Proteases.

Nikam A, Dawra R, Saluja A, Dudeja V.

Gastroenterology. 2018 Feb;154(3):482-484. doi: 10.1053/j.gastro.2018.01.017. Epub 2018 Jan 11. No abstract available.

PMID:
29337153
22.

Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.

Dauer P, Zhao X, Gupta VK, Sharma N, Kesh K, Gnamlin P, Dudeja V, Vickers SM, Banerjee S, Saluja A.

Cancer Res. 2018 Mar 1;78(5):1321-1333. doi: 10.1158/0008-5472.CAN-17-2320. Epub 2017 Dec 19.

23.

NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling.

Nomura A, Gupta VK, Dauer P, Sharma NS, Dudeja V, Merchant N, Saluja AK, Banerjee S.

Mol Cancer Res. 2018 Jan;16(1):162-172. doi: 10.1158/1541-7786.MCR-17-0221. Epub 2017 Sep 28.

24.

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.

McGinn O, Gupta VK, Dauer P, Arora N, Sharma N, Nomura A, Dudeja V, Saluja A, Banerjee S.

Sci Rep. 2017 Aug 11;7(1):7872. doi: 10.1038/s41598-017-08447-3.

25.

The Impact of Surgeon Volume on Outcomes After Pancreaticoduodenectomy: a Meta-analysis.

Macedo FIB, Jayanthi P, Mowzoon M, Yakoub D, Dudeja V, Merchant N.

J Gastrointest Surg. 2017 Oct;21(10):1723-1731. doi: 10.1007/s11605-017-3498-7. Epub 2017 Jul 25.

PMID:
28744743
26.

Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.

Giri B, Sethi V, Dudeja V, Banerjee S, Livingstone A, Saluja A.

Curr Opin Gastroenterol. 2017 Sep;33(5):404-410. doi: 10.1097/MOG.0000000000000382. Review.

PMID:
28682795
27.

Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis.

Barlass U, Dutta R, Cheema H, George J, Sareen A, Dixit A, Yuan Z, Giri B, Meng J, Banerjee S, Banerjee S, Dudeja V, Dawra RK, Roy S, Saluja AK.

Gut. 2018 Apr;67(4):600-602. doi: 10.1136/gutjnl-2017-313717. Epub 2017 Jun 22.

PMID:
28642332
28.

"Heat shock protein 70 in pancreatic diseases: Friend or foe".

Giri B, Sethi V, Modi S, Garg B, Banerjee S, Saluja A, Dudeja V.

J Surg Oncol. 2017 Jul;116(1):114-122. doi: 10.1002/jso.24653. Epub 2017 May 22. Review.

29.

Insights into the Pathogenesis of Pancreatic Cystic Neoplasms.

Sethi V, Giri B, Saluja A, Dudeja V.

Dig Dis Sci. 2017 Jul;62(7):1778-1786. doi: 10.1007/s10620-017-4603-1. Epub 2017 May 12. Review.

30.

Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies.

Creasy JM, Goldman DA, Gonen M, Dudeja V, Askan G, Basturk O, Balachandran VP, Allen PJ, DeMatteo RP, D'Angelica MI, Jarnagin WR, Peter Kingham T.

J Gastrointest Surg. 2017 Aug;21(8):1254-1261. doi: 10.1007/s11605-017-3436-8. Epub 2017 May 8.

31.

Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer.

Dauer P, Gupta VK, McGinn O, Nomura A, Sharma NS, Arora N, Giri B, Dudeja V, Saluja AK, Banerjee S.

Sci Rep. 2017 May 8;7(1):1564. doi: 10.1038/s41598-017-01696-2.

32.

Why Do Long-Distance Travelers Have Improved Pancreatectomy Outcomes?

Jindal M, Zheng C, Quadri HS, Ihemelandu CU, Hong YK, Smith AK, Dudeja V, Shara NM, Johnson LB, Al-Refaie WB.

J Am Coll Surg. 2017 Aug;225(2):216-225. doi: 10.1016/j.jamcollsurg.2017.04.003. Epub 2017 Apr 14.

33.

Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes.

Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, Allen PJ, DeMatteo RP, Kingham TP, D'Angelica MI, Jarnagin WR.

J Am Coll Surg. 2017 May;224(5):906-916. doi: 10.1016/j.jamcollsurg.2016.12.058. Epub 2017 Feb 13.

34.

Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.

Arora N, Alsaied O, Dauer P, Majumder K, Modi S, Giri B, Dudeja V, Banerjee S, Von Hoff D, Saluja A.

PLoS One. 2017 Feb 13;12(2):e0171827. doi: 10.1371/journal.pone.0171827. eCollection 2017.

35.

Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.

Isharwal S, Modi S, Arora N, Uhlrich C 3rd, Giri B, Barlass U, Soubra A, Chugh R, Dehm SM, Dudeja V, Saluja A, Banerjee S, Konety B.

Prostate. 2017 May;77(6):584-596. doi: 10.1002/pros.23298. Epub 2017 Feb 1.

36.

Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer.

Garg B, Giri B, Majumder K, Dudeja V, Banerjee S, Saluja A.

Cancer Lett. 2017 Mar 1;388:64-72. doi: 10.1016/j.canlet.2016.11.026. Epub 2016 Dec 3.

PMID:
27919787
37.

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer.

Nomura A, Majumder K, Giri B, Dauer P, Dudeja V, Roy S, Banerjee S, Saluja AK.

Lab Invest. 2016 Dec;96(12):1268-1278. doi: 10.1038/labinvest.2016.109. Epub 2016 Oct 24.

38.

Comprehensive analysis of microRNA signature of mouse pancreatic acini: overexpression of miR-21-3p in acute pancreatitis.

Dixit AK, Sarver AE, Yuan Z, George J, Barlass U, Cheema H, Sareen A, Banerjee S, Dudeja V, Dawra R, Subramanian S, Saluja AK.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G974-G980. doi: 10.1152/ajpgi.00191.2016. Epub 2016 Sep 29.

39.

Release of Cathepsin B in Cytosol Causes Cell Death in Acute Pancreatitis.

Talukdar R, Sareen A, Zhu H, Yuan Z, Dixit A, Cheema H, George J, Barlass U, Sah R, Garg SK, Banerjee S, Garg P, Dudeja V, Dawra R, Saluja AK.

Gastroenterology. 2016 Oct;151(4):747-758.e5. doi: 10.1053/j.gastro.2016.06.042. Epub 2016 Aug 9.

40.

Is age just a number: pancreaticoduodenectomy in elderly patients?

Dudeja V, Livingstone A.

Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):346-7. No abstract available.

PMID:
27498573
41.

Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells.

Nomura A, Dauer P, Gupta V, McGinn O, Arora N, Majumdar K, Uhlrich C 3rd, Dalluge J, Dudeja V, Saluja A, Banerjee S.

Oncotarget. 2016 Aug 30;7(35):56324-56337. doi: 10.18632/oncotarget.10838.

42.

Evolution of novel therapeutic options for pancreatic cancer.

Saluja AK, Dudeja V, Banerjee S.

Curr Opin Gastroenterol. 2016 Sep;32(5):401-407. doi: 10.1097/MOG.0000000000000298.

43.

Effect of MRI Versus MDCT on Milan Criteria Scores and Liver Transplantation Eligibility.

Rostambeigi N, Taylor AJ, Golzarian J, Jensen EH, Pruett TL, Dudeja V, D'Souza D.

AJR Am J Roentgenol. 2016 Apr;206(4):726-33. doi: 10.2214/AJR.15.14642. Epub 2016 Jan 21. Erratum in: AJR Am J Roentgenol. 2016 Jul;207 (1):226.

PMID:
26796867
44.

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.

Nomura A, McGinn O, Dudeja V, Sangwan V, Saluja AK, Banerjee S.

Mol Cancer. 2015 Nov 23;14:200. doi: 10.1186/s12943-015-0470-6.

45.

A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.

Majumder K, Arora N, Modi S, Chugh R, Nomura A, Giri B, Dawra R, Ramakrishnan S, Banerjee S, Saluja A, Dudeja V.

J Gastrointest Surg. 2016 Jan;20(1):53-65; discussion 65. doi: 10.1007/s11605-015-2985-y. Epub 2015 Nov 18.

46.

Neutrophil Extracellular Traps Provide a Grip on the Enigmatic Pathogenesis of Acute Pancreatitis.

Korhonen JT, Dudeja V, Dawra R, Kubes P, Saluja A.

Gastroenterology. 2015 Dec;149(7):1682-5. doi: 10.1053/j.gastro.2015.10.027. Epub 2015 Oct 23. No abstract available.

PMID:
26505817
47.

Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.

Modi S, Kir D, Giri B, Majumder K, Arora N, Dudeja V, Banerjee S, Saluja AK.

J Gastrointest Surg. 2016 Jan;20(1):13-23; discussion 23-4. doi: 10.1007/s11605-015-3000-3. Epub 2015 Oct 26.

48.

Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.

Banerjee S, Modi S, McGinn O, Zhao X, Dudeja V, Ramakrishnan S, Saluja AK.

Clin Cancer Res. 2016 Jan 15;22(2):415-25. doi: 10.1158/1078-0432.CCR-15-1155. Epub 2015 Sep 24.

49.

Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.

Oliveira A, Beyer G, Chugh R, Skube SJ, Majumder K, Banerjee S, Sangwan V, Li L, Dawra R, Subramanian S, Saluja A, Dudeja V.

Lab Invest. 2015 Jun;95(6):648-659. doi: 10.1038/labinvest.2015.46. Epub 2015 Apr 20.

50.

Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.

Sangwan V, Banerjee S, Jensen KM, Chen Z, Chugh R, Dudeja V, Vickers SM, Saluja AK.

Pancreas. 2015 May;44(4):583-9. doi: 10.1097/MPA.0000000000000317.

Supplemental Content

Loading ...
Support Center